Grade 3 Hepatotoxicity following Fulvestrant, Palbociclib, and Erdafitinib Therapy in a Patient with ER-Positive/PR-Negative/HER2-Negative Metastatic Breast Cancer: En case report

Abstract En 49-årig kvinde med ER-positiv/PR-negativ/HER2-negativ metastatisk brystkræft oplevede grad 3 hepatotoksicitet efter påbegyndelse af et klinisk forsøg med fulvestrant,

Continue readingGrade 3 Hepatotoxicity following Fulvestrant, Palbociclib, and Erdafitinib Therapy in a Patient with ER-Positive/PR-Negative/HER2-Negative Metastatic Breast Cancer: En case report